Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients

NCT00206960 is registered in ClinicalTrials.gov with Birte Glenthoj as lead sponsor.

NCT NCT00206960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00206960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Classical and Atypical Antipsychotics on Dopamine Receptor Binding of 123I-epidepride, Cognition, Startle Response and Extrapyramidal Side-effects in Drug-naive First-episode Schizophrenic Patients
Lead sponsor
Birte Glenthoj
Phase
Not applicable
Overall status
Completed
Start date
January 31, 1998
Completion date
September 30, 2010
Enrollment
56 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia